MedTrace Logo

Effect of Atorvastatin on Carotid Intima Media Thickness

NCT04306627 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2020-03-13

No results posted yet for this study

Summary

The investigators hypothesize that additive effects of combined antihypertensive medications and statin in a single pill combination may better reduce progression of vascular remodeling and inhibit atherosclerosis progression. The fixed association of atorvastatin, perindopril and amlodipine under the name of Lipertance is the first fixed combination of these three groups to control the risk factors that are hypertension and dyslipidemia which can be used both in primary and secondary cardiovascular prevention .

Conditions

Interventions

DRUG

Perindopril/Amlodipine and Perindopril/Amlodipine/Atorvastatin treatment

comparative antihypertensive antilipidemic treatment assessment on carotid intima media thickness in both study groups

Sponsors & Collaborators

  • Servier

    collaborator INDUSTRY

  • Yerevan State Medical University

    lead OTHER

Principal Investigators

  • Hamayak Sisakian, MD · Yerevan State Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-15
Primary Completion
2020-10-16
Completion
2021-02-28

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04306627 on ClinicalTrials.gov